Browse All

Current Filters

CLEAR FILTER x

TITLE

The Synuclein-One Study: Skin Biopsy Detection of Phosphorylated alpha-synuclein for Diagnosis of the Synucleinopathies

Author:Gibbons, Christopher   Bellaire, Bailey   Wang, Ningshan   Freeman, Roy   Adler, Charles   Miglis, Mitchell   Isaacson, Stuart   Evidente, Virgilio Gerald   Soileau, Michael   Gudesblatt, Mark   Lamotte, Guillaume   Kumar, Rajeev   Petrossian, Melita   Gonzalez Duarte, Maria Alejandra   Khemani, Pravin   Saint-Hilaire, Marie-Helene   McFarland, Nikolaus   Pandey, Hemant   Yerstein, Oleg   Barboi, Alexandru   Liu, Andrew   Levine, Todd   

Session Name:S37: Movement Disorders: Phenotyping and Biomarkers  

Topic:Movement Disorders  

Program Number:S37.004  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  CND Life Sciences, Phoenix, AZ  BIDMC, Boston, MA  Beth Israel Deaconess Hosp, Boston, MA  Mayo Clinic Arizona, Scottsdale, AZ  Stanford University Medical Center, Stanford, CA  Parkinson’s Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL  Movement Disorders Center of Arizona, Scottsdale, AZ  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  South Shore Neurologic Associates, Patchogue, NY  University of Utah, Salt Lake City, UT  Rocky Mountain Movement Disorders Center, Englewood, CO  Pacific Movement Disorders Center, Santa Monica, CA  NYU, new york, NY  Swedish Neuroscience Institute, Seattle, WA  Boston University School of Medicine, Roxbury, MA  University of Florida, Gainesville, FL  Brain and Spine Center, CHANDLER, AZ  Lahey Hospital & Medical Center, Burlington, MA  NorthShore University, Glenview, IL  Duke Health, Durham, NC  Honor Health, Scottsdale, AZ  

Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study

Author:Bowen, James   Stulc, Jessica   Hunter, Samuel   Antezana, Ariel   Chen, Hailu   Lewin, James   Scaramozza, Matthew   Bozin, Ivan   Then Bergh, Florian   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.001  

Author Institution:Swedish Neuroscience Institute, Seattle, WA  Minneapolis Clinic of Neurology, Golden Valley, MN  Advanced Neurosciences Institute, Franklin, TN  Neuromedical Clinic of Central Louisiana, Alexandria, LA  Biogen Inc., Cambridge, MA  University of Leipzig, Klinik u. Poliklinik fuer Neurologie, Leipzig, Germany